CARL ZEISS MEDITEC ADR 1 (AFXA) — Net Asset Momentum
CARL ZEISS MEDITEC ADR 1 (AFXA) recorded a net asset momentum of 3.5% as of September 2025, with net assets of €2.13 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CARL ZEISS MEDITEC ADR 1 (AFXA) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
CARL ZEISS MEDITEC ADR 1 Net Asset Momentum (2022–2025)
This chart tracks CARL ZEISS MEDITEC ADR 1's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +3.5%, with net assets of €2.13 Billion EUR as of September 2025. For live market cap and overall valuation, see AFXA market cap.
Annual Net Asset History for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below shows the complete annual net asset history for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check AFXA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €2.13 Billion | €3.40 Billion | €1.28 Billion | ▲ +3.5% |
| 2024 | €2.06 Billion | €3.39 Billion | €1.34 Billion | ▼ -5.4% |
| 2023 | €2.17 Billion | €3.03 Billion | €860.02 Million | ▲ +7.0% |
| 2022 | €2.03 Billion | €2.82 Billion | €792.73 Million | — |